•
LU
LUCD
Lucid Diagnostics Inc. Common Stock
polygonSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
158.63M
Volume
32.14M
52W High
$1.80
52W Low
$0.81
Open
$1.59
Prev Close
$1.21
Day Range
1.12 - 1.63
About Lucid Diagnostics Inc. Common Stock
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Latest News
PAVmed Announces Reverse Stock Split
Benzinga•Dec 30
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Benzinga•Oct 29
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Benzinga•Sep 9
PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
Benzinga•Oct 31
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
Benzinga•Oct 9
Where Lucid Diagnostics Stands With Analysts
Benzinga•May 17
10 Biggest Price Target Changes For Tuesday
Benzinga•Mar 29
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Benzinga•Nov 8